The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting an …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected 78 million
individuals and is responsible for over 1.7 million deaths to date. Infection is associated with the …

Background & Aims Given that gastrointestinal (GI) symptoms are a prominent extrapulmonary
manifestation of COVID-19, we investigated intestinal infection with SARS-CoV-2, its …

Background: Despite its functional importance in various fundamental bioprocesses, studies
of N 6 -methyladenosine (m6A) in the heart are lacking. Here, we show that the FTO (fat …

B cells, which are critical for intestinal homeostasis, remain understudied in ulcerative colitis
(UC). In this study, we recruited three cohorts of patients with UC (primary cohort, n = 145; …

… Author links open overlay panel Mayte Suárez-Fariñas 1 2 ∗ , Minami Tokuyama 3 4 ∗ ,
Gabrielle Wei 2 5 , Ruiqi Huang 1 2 , Alexandra Livanos 3 4 , Divya Jha 3 4 , Anais Levescot 6 7 …

Given that gastrointestinal (GI) symptoms are a prominent extrapulmonary manifestation of
coronavirus disease 2019 (COVID-19), we investigated intestinal infection with severe acute …

Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut
immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of …

Vedolizumab (VDZ) is a first-line treatment in ulcerative colitis (UC) that targets the α4β7-
mucosal vascular addressin cell adhesion molecule 1 (MAdCAM-1) axis. To determine the …

Infectious diseases are globally associated with high mortality in spite of the availability of
therapeutic agents against most pathogenic microorganisms. This is due to the emergence of …